FilingReader Intelligence

Hualan Bio invests CNY 500m in Hualan Gene

July 8, 2025 at 05:13 PM UTCBy FilingReader AI

Hualan Biological Engineering (SZSE:002007) has announced a CNY 500 million investment in its subsidiary, Hualan Gene Engineering Co., Ltd. The investment, executed at CNY 1 per CNY 5 of registered capital, will be made proportionally by existing shareholders. Hualan Bio will contribute CNY 200 million to maintain its 40% ownership, while actual controller An Kang will invest CNY 300 million to retain his 60% stake.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:002007Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Hualan Biological Engineering publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →